Fischer Medical Ventures Ltd.

•

fischermv.comBSE: 524743NSE: FISCHER

Market Cap₹ 2,647 Cr.

Current Price

High / Low₹ 125 / 31

Stock P/E88.7

Book Value₹ 7

Price to Book18.64

Dividend Yield0.00 %

ROCE1.1 %

ROE0.6 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Oil Gas & Consumable Fuels

Reduce

Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.

Confidence

78%

View full sector analysis →

PROS

Working capital cycle has improved - days down from 1158 to 869
Company maintains a comfortable, low leverage position

CONS

Operating cash flow has been negative in recent years
A large part of profit comes from other income (67.1% of PBT)
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -31.27x)
Promoter holding has decreased over last 2 years: -12.8pp
Company has a low return on equity of 1.7% over last 3 years
Company has a low return on capital employed of 3.8%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Oil Gas & Consumable FuelsTradingTrading

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	ADANIENT	2894.80	52.64	391875.62	0.04	-1461.54	-249.67	32923.98	49.92	13.30	15.57
2.	PREMIERENE	999.50	27.25	45372.45	0.10	471.92	53.32	2462.59	35.25	33.72	29.03
3.	CPPLUS	3715.75	92.10	43957.48	0.04	142.20	332.51	1402.42	89.51	29.48	14.52
4.	AEGISLOG	1242.80	34.86	43622.28	0.70	544.84	210.70	2356.86	37.07	19.76	30.28
5.	REDINGTON	363.00	16.68	28378.41	1.65	453.49	94.65	34922.47	34.57	18.96	2.03
6.	HONASA	470.45	61.63	15337.81	0.64	90.45	118.87	755.95	27.00	8.99	14.58
7.	LLOYDSENT	70.95	96.45	10830.89	0.21	109.98	-55.77	563.03	70.15	12.84	18.07
8.	SGMART	825.65	83.70	10406.10	0.00	455.80	1310.71	13085.70	1044.08	10.43	4.49
9.	MMTC	62.14	20.84	9321.00	0.00	104.24	135.52	0.68	-50.00	33.46	-1423.53
10.	ENTERO	1799.70	62.46	7832.85	0.00	52.05	72.17	1940.50	38.23	10.93	5.00
11.	CELLO	346.70	24.48	7658.08	0.43	73.40	-8.99	526.72	-0.43	17.15	18.80
12.	FISCHER	37.88	88.74	2646.62	0.00	3.79	-24.30	81.92	249.34	1.13	13.73

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	21	10	40	12	49	23	86	101	98	82
	18	10	39	11	47	19	70	80	97	76
Operating Profit	3	-0	0	0	3	4	16	22	1	11
OPM %	12.07%	-2.47%	1.26%	4.26%	5.10%	17.19%	18.83%	21.34%	1.03%	13.73%
Other Income	0	1	0	0	0	7	2	1	1	1
Interest	0	0	0	0	0	1	1	1	4	4
Depreciation	0	0	0	1	1	1	1	1	1	1
	3	0	0	0	2	10	17	21	-2	8
Tax %	6.18%	237.50%	-21.05%	168.00%	26.04%	50.84%	19.48%	9.18%	-216.00%	51.60%
Net Profit	0	-0	0	-3	1	5	14	19	-7	4
	1	-0	0	-0	0	0	2	0	-0	0
Equity Capital	54	54	54	54	64	65	65	65	65	65
Reserves	0	0	0	0	0	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	TTM
	0	21	111	367
	0	19	107	322
Operating Profit	0	2	5	—
OPM %	8	11	4	—
Other Income	0	1	1	6
Interest	0	0	0	9
Depreciation	0	0	2	4
	-0	2	2	44
Tax %	-2,708	13	46	32
Net Profit	-0	2	1	30
EPS	-2	0	0	—
Dividend Payout %	0	0	22	—
Minority Interest	0	-0	0	0
Share of Associates	0	0	0	-0
Adjusted EPS	-0	0	0	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: -66%

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: 2%
Last Year:: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025
LIABILITIES	-	-	-
Equity Capital	0	54	64
	-0	27	244
	0	0	60
Trade Payables	0	2	21
	0	4	69
Total Liabilities	0	86	457
ASSETS	-	-	-
	0	15	24
Capital Work in Progress	0	0	1
	0	1	11
	0	4	9
	0	23	76
Cash & Bank	0	38	251
	0	5	85
Total Assets	0	86	457
Total Debt	1	0	60
Net Working Capital	0	67	263
Contingent Liabilities	0	0	0
Book Value per Share	-15.47	15.00	48.17
Face Value	10.00	10.00	10.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025
	0	-7	-87
Cash from Investing	0	-31	-125
Cash from Financing	0	37	315
	0	-2	103
Free Cash Flow	0	-23	-99
OCF / Net Profit	-0.00	-4.00	-71.81
Cumulative 5-Year FCF	0	0	0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	-2.12	0.26	0.23
Book Value (₹)	-15.47	15.00	48.17
Dividend per Share (₹)	0.00	0.00	0.05
Cash EPS (₹)	-0.21	0.04	0.04
PROFITABILITY
Operating Margin %	8.47%	8.86%	3.02%
Net Margin %	-20.33%	8.76%	1.09%
ROE %	0.00%	4.60%	0.62%
ROCE %	4.97%	5.35%	1.13%
	-14.72%	4.25%	0.44%
EFFICIENCY
Debtor Days	347	200	163
Inventory Days	0	78	22
Payable Days	0	24	45
	347	254	140
FINANCIAL HEALTH
Debt to Equity (x)	-2.15x	0.00x	0.20x
Interest Coverage (x)	0.92x	32.23x	5.50x
	5.18x	18.37x	3.59x
GROWTH
Revenue Growth %	0.00%	0.00%	427.61%
Operating Profit Growth %	0.00%	0.00%	104.82%
Net Profit Growth %	0.00%	5135.34%	-34.28%
	0.00%	112.14%	-9.86%
VALUATION
P/E (x)	0.00x	242.49x	386.61x
P/B (x)	0.00x	41.65x	18.64x
Dividend Yield %	0.00%	0.00%	0.01%
	0.00x	1399.44x	1144.95x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	74.91	74.91	74.91	62.81	61.80	61.80	61.80	62.15	62.15
	5.07	5.07	5.07	5.23	5.55	5.57	4.85	4.97	5.48
	1.68	1.68	1.68	1.44	1.42	1.42	1.36	1.38	1.35
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	18.33	18.33	18.33	30.51	31.23	31.21	31.99	31.50	31.02

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03

Outcome of Board Meeting

2026-09-03 - Fischer Medical Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.

2026-09-03

General Updates

2026-09-03 - Fischer Medical Ventures Limited has informed the Exchange about outcome of Board meeting held on 03/09/2026

2026-09-03

Record Date

2026-09-03 - Fischer Medical Ventures Limited has informed the Exchange that Record date for the purpose of Dividend is 22-Sep-2026.

2026-08-28

Press Release

2026-08-28 - Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated August 28, 2026, titled "Time Medical International Ventures Launches Next-Generation CLARION 64/128-Slice AI-Driven CT System at India Health Expo 2026".

2026-08-24

Press Release

2026-08-24 - Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated August 24, 2026, titled "Catanduanes Integrated Digital Healthcare Project Awarded to Time Medical Philippines Advancing the Digitalization of Universal Health Care in the Philippines".

2026-08-17

General Updates

2026-08-17 - Fischer Medical Ventures Limited has informed the Exchange on the allotment of Equity shares pursuant to conversion of warrants

2026-08-15

Resignation of Director/KMP/SMP

2026-08-15 - Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-15

Resignation of Director/KMP/SMP

2026-08-15 - Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-14

General Updates

2026-08-14 - Fischer Medical Ventures Limited has informed the Exchange on allotment of Equity shares pursuant to conversion of warrants

News

Recent coverage and analyst commentary for FISCHER

Loading news…

🤖

AI Stock Analyst

Fischer Medical Ventures Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

ADANIENT

2894.80

52.64

391875.62

0.04

-1461.54

-249.67

32923.98

49.92

13.30

15.57

PREMIERENE

999.50

27.25

45372.45

0.10

471.92

53.32

2462.59

35.25

33.72

29.03

CPPLUS

3715.75

92.10

43957.48

0.04

142.20

332.51

1402.42

89.51

29.48

14.52

AEGISLOG

1242.80

34.86

43622.28

0.70

544.84

210.70

2356.86

37.07

19.76

30.28

REDINGTON

363.00

16.68

28378.41

1.65

453.49

94.65

34922.47

34.57

18.96

2.03

HONASA

470.45

61.63

15337.81

0.64

90.45

118.87

755.95

27.00

8.99

14.58

LLOYDSENT

70.95

96.45

10830.89

0.21

109.98

-55.77

563.03

70.15

12.84

18.07

SGMART

825.65

83.70

10406.10

0.00

455.80

1310.71

13085.70

1044.08

10.43

4.49

MMTC

62.14

20.84

9321.00

0.00

104.24

135.52

0.68

-50.00

33.46

-1423.53

ENTERO

1799.70

62.46

7832.85

0.00

52.05

72.17

1940.50

38.23

10.93

5.00

CELLO

346.70

24.48

7658.08

0.43

73.40

-8.99

526.72

-0.43

17.15

18.80

FISCHER

37.88

88.74

2646.62

0.00

3.79

-24.30

81.92

249.34

1.13

13.73

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

101

Operating Profit

-0

OPM %

12.07%

-2.47%

1.26%

4.26%

5.10%

17.19%

18.83%

21.34%

1.03%

13.73%

Other Income

Interest

Depreciation

-2

Tax %

6.18%

237.50%

-21.05%

168.00%

26.04%

50.84%

19.48%

9.18%

-216.00%

51.60%

Net Profit

-0

-3

-7

-0

Equity Capital

Reserves

Promoter Pledge %

0.00%

Mar 2023

Mar 2024

Mar 2025

TTM

111

367

107

322

Operating Profit

—

OPM %

—

Other Income

Interest

Depreciation

-0

Tax %

-2,708

Net Profit

-0

EPS

-2

—

Dividend Payout %

—

Minority Interest

-0

Share of Associates

-0

Adjusted EPS

-0

—

Mar 2023

Mar 2024

Mar 2025

LIABILITIES

Equity Capital

-0

244

Trade Payables

Total Liabilities

457

ASSETS

Capital Work in Progress

Cash & Bank

251

Total Assets

457

Total Debt

Net Working Capital

263

Contingent Liabilities

Book Value per Share

-15.47

15.00

48.17

Face Value

10.00

Mar 2023

Mar 2024

Mar 2025

-7

-87

Cash from Investing

-31

-125

Cash from Financing

315

-2

103

Free Cash Flow

-23

-99

OCF / Net Profit

-0.00

-4.00

-71.81

Cumulative 5-Year FCF

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

-2.12

0.26

0.23

Book Value (₹)

-15.47

15.00

48.17

Dividend per Share (₹)

0.00

0.05

Cash EPS (₹)

-0.21

0.04

PROFITABILITY

Operating Margin %

8.47%

8.86%

3.02%

Net Margin %

-20.33%

8.76%

1.09%

ROE %

0.00%

4.60%

0.62%

ROCE %

4.97%

5.35%

1.13%

-14.72%

4.25%

0.44%

EFFICIENCY

Debtor Days

347

200

163

Inventory Days

Payable Days

347

254

140

FINANCIAL HEALTH

Debt to Equity (x)

-2.15x

0.00x

0.20x

Interest Coverage (x)

0.92x

32.23x

5.50x

5.18x

18.37x

3.59x

GROWTH

Revenue Growth %

0.00%

427.61%

Operating Profit Growth %

0.00%

104.82%

Net Profit Growth %

0.00%

5135.34%

-34.28%

0.00%

112.14%

-9.86%

VALUATION

P/E (x)

0.00x

242.49x

386.61x

P/B (x)

0.00x

41.65x

18.64x

Dividend Yield %

0.00%

0.01%

0.00x

1399.44x

1144.95x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

74.91

62.81

61.80

62.15

5.07

5.23

5.55

5.57

4.85

4.97

5.48

1.68

1.44

1.42

1.36

1.38

1.35

Government

0.00

18.33

30.51

31.23

31.21

31.99

31.50

31.02

Fischer Medical Ventures Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Fischer Medical Ventures Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI